Kirubakaran Munuswamy, MD
Mon-Fri 8:30am to 5:00pm
Click here to watch Dr. Munuswamy's Webisode: Karan Munuswamy, MD
Current Leadership Positions
President, American Diabetes Association Broward County Chapter
National Executive Committee Member, Association of Physicians from India
Cardiology, nuclear cardiology, cardiovascular computed tomography angiography, heart failure, lipid abnormalities, risk stratification before surgery and hypertension
Notable Work Experience
Chief of Medical Staff - Pompano Beach Medical Center - Pompano Beach, FL (1993, 1995)
Member of Board of Trustees - Pompano Beach Medical Center - Pompano Beach, FL (1995-1997)
Director of Cardiac Catheterization Laboratory - Pompano Beach Medical Center - Pompano Beach, FL (1989-1997)
American Board of Internal Medicine
American Board of Internal Medicine - Cardiovascular Medicine
American Board of Nuclear Cardiology
American Society of Hypertension Specialist Program
Cardiovascular Computed Tomography Angiography (Cardiac CTA)
Cardiology, University of Missouri Health Sciences Center - Columbia, MO (1981-1983)
Residency, Internal Medicine - St. Francis Medical Center (affiliated with Hahnemann Medical College) - Trenton, NJ (1980-1981)
Internship, Surgery - St. Francis Medical Center - Trenton, NJ (1977-1978)
Internship, Rotating - Osmania General Hospital - Hyderabad, India (1974-1975)
Institute of Medical Sciences, Osmania Medical College - Medical Degree - Hyderabad, India (1968-1974)
American Diabetes Association
Society of Cardiovascular Computed Tomography
American College of Cardiology
American Association of Physicians from India
American Heart Association
Achievement Award (Valor Award), American Diabetes Association (2004, 2011)
Humanitarian Award, Opera Society of Broward (2003)
Most Outstanding Resident of the Year, St. Francis Medical Center - Trenton, NJ (1980)
1) Munuswamy K, Alpert MA, Martin RH, Whiting RB, Mechlin J. American Journal of Cardiology. March 1984. Sensitivity and Specificity of
Commonly Used Electrocardiologic Criteria for Left Atrial Enlargement Determined by M-Mode Echocardiography.
2) Munuswamy K, Alpert MA, Madigan NP, Parker BM. January 1993. Southern Medical Journal. Ventricular Septal Rupture Following Acute
Myocardial Infarction. Diagnosis with 2-Dimensional Echocardiography.
3) Alpert MA, Carney R, Munuswamy K. December 1986. American Heart Journal. Observer Variability in Diagnosing Mitral Valve Prolapse by
4) Flaker G, Munuswamy K. Continuing Education for the Family Physician. Evaluation of Syncope with Intracardiac Electrophysiological
Testing. Volume 19, No. 18, 453-462.
5) Levites R, Hajitz G, Munuswamy K. July 1981. JAMA. Febrile Reaction to Sulindac. Vol 246, Issue 3.
6) Flaker G, Munuswamy K. November 1982. American Family Physicians. New Antiarrhythmic Drugs: Theoretical and Practical Applications.
Volume 26(5): 226-232.
"A Phase 3, Parallel, Double-Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection with BMC068645 and Adenosine Stress Single Photon Emission Computed Tomography (SPECT) Compared to Coronary Angiography" - Bristol Meyers Squibb Medical Imaging
"A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Patients who are to Undergo Percutaneious Coronary Intervention" TRITON-TIMI 38 (Protocol H7T-MC-TAAL) - Eli Lilly and Company
"TRENDS" - Medtronic
"A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial to Compare the Effects of Lotrel (amlodipine/benazepril) to benazepril and hydrochlorotiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension"
(ACCOMPLISH - Avoiding Cardiovascular Events through Combination Therapy in patients Living with Systolic Hypertension) - Novartis Pharmaceuticals
"Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in SUbjects Hospitalized with Worsening Congestive Heart Failure" (156-03-236) - Otsuka Maryland Research Institute
"Rapid Assessment of Bedside BNP in the Treatment of Heart Failure" (RABBIT) - Biosite, Inc.
"Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy Study on the Effects of Oral Tolvaptan on Left Ventricular Dilatation and Function in patients with Heart Failure and Left Ventricular Systolic Dysfunction" (METEOR) - Otsuka Maryland Research Institute
"Omapatrilat Cardiovascular Treatment Assessment versus Enalapril" (OCTAVE)
"Candesartan Cilexetil in Heart Failure: Assessment of Reductio in Mortality and Morbidity" (CHARM)
"Phase III International Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Orbofiban in Patients with Unstable Coronary Syndromes" (OPUS-TIMI 16 Trial) - Searle & Co. Pharmaceutical Protocol# 159-97-02-026: IND# 49380
"Sudden Cardiac Death and Heart Failure Trial" (SCD-HeFT) - National Institutes of Health
"MIL-SW-027 A Double-Blind, Randomized, Multicenter Study to Evaluate the Effectiveness of Intravenous Milrinone versus Placebo in Reducing the Number of Days of Hospitalization in the 60 Days Following Entry into the Study for Treatment of Left-Sided Heart Failure" (OPTIME)